Shaw lenses are a specialized prescription lens design that simultaneously reduces aniseikonia — the unequal image size perceived by each eye — making them uniquely valuable for people with different prescriptions in their two eyes who struggle with standard glasses.

Low-dose atropine eye drops (0.01 to 0.05 percent) are an evidence-based myopia control treatment that slows axial elongation by 50 to 77 percent with minimal side effects, and they are considered safe for long-term use in children when monitored by a qualified optometrist.

Stellest lenses are prescription eyeglass lenses containing hundreds of micro-lenslets that create a myopic defocus signal in the peripheral retina, slowing the eye's axial growth and reducing myopia progression by an average of 67 percent.

Orthokeratology involves wearing specially designed contact lenses overnight to reshape the cornea and provide clear daytime vision without glasses, and decades of research confirm it is safe for children while also effectively slowing myopia progression.

MiSight 1-day contact lenses are FDA-approved daily disposable lenses that simultaneously correct myopia and slow its progression by creating a peripheral myopic defocus signal, with clinical trials showing an average 59 percent reduction in progression over three years.

Several evidence-based treatments can slow myopia progression in children by 40 to 70 percent, including orthokeratology, MiSight contact lenses, Stellest spectacle lenses, and atropine eye drops — with the best option depending on the child's age, lifestyle, and degree of myopia.

Anti-fatigue lenses are progressive-style spectacle lenses with a small amount of reading add power at the bottom that reduces the strain of sustained near work, and they can be helpful for children who experience headaches or eye fatigue from extended reading and screen use.